Urinary bladder cancer
Clinical trials for Urinary bladder cancer explained in plain language.
Never miss a new study
Get alerted when new Urinary bladder cancer trials appear
Sign up with your email to follow new studies for Urinary bladder cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill target cancers with a specific gene flaw?
Disease control Not yet recruitingThis phase II trial tests an experimental drug called TR115 in people with advanced solid tumors that have a mutation in the ARID1A gene. The study includes patients with platinum-resistant ovarian clear cell carcinoma, endometrial cancer that failed immunotherapy, and other tumo…
Matched conditions: URINARY BLADDER CANCER
Phase 2 • Sponsor: Tarapeutics Science Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Promising combo aims to shrink bladder tumors before surgery
Disease control Not yet recruitingThis study tests whether combining two drugs (trastuzumab rezetecan and camrelizumab) before surgery can improve outcomes for people with a certain type of muscle-invasive bladder cancer (HER2-positive). About 44 adults will receive the treatment to see if it helps eliminate canc…
Matched conditions: URINARY BLADDER CANCER
Phase 2 • Sponsor: Sheng Tai • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Bladder cancer: can faster chemo before surgery boost cure rates?
Disease control Not yet recruitingThis phase 2 trial tests a dose-dense (faster) schedule of two chemotherapy drugs, gemcitabine and cisplatin, given before surgery for muscle-invasive bladder cancer. The goal is to see if this approach can completely eliminate the tumor in the bladder and lymph nodes. Thirty eli…
Matched conditions: URINARY BLADDER CANCER
Phase 2 • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 26, 2026 19:10 UTC